TScan Therapeutics Announces Closing of Upsized Public Offering
GlobeNewswire
WALTHAM, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical..
WALTHAM, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical..
EQS-News: Evotec SE / Key word(s): Miscellaneous
Evotec and Variant Bio enter strategic partnership to discover and develop..
The government long ago sold us out to the highest bidder.
The highest bidder, by the way, has always been the Deep..